Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Asan Medical Center, Seoul, Korea, Republic of
Asan Medical Center, Seoul, Korea, Republic of
Fujian provincial hospital, Fuzhou, Fujian, China
Maternal and Child Health Hospital of Hubei Province, Wuhan, Hubei, China
Tumor Hospital of Jiangxi Province, Nanchang, Jiangxi, China
People's Hospital of Ganzhou, Ganzhou, Jiangxi, China
the First Affiliated Hospital of Gannan Medical College, Gannan Medical College, Ganzhou, Jiangxi, China
Beijing Tiantan Hospital, Capital Medical University, Beijing, China
ICON (LPRA) - Salt Lake, Salt Lake City, Utah, United States
CHU Brugmann, Brussels, Belgium
Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
Southern medical university Nanfang hospital, Guangzhou, Guangdong, China
Mona Mohamed Mogahed, Tanta, Elgharbia, Egypt
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.